COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-69145

“..3.2 percent of study participants who got the updated bivalent vaccine became infected – compared to just 1.9 percent of those who received the original booster…”

• Moderna ‘Withheld Trial Data’ On Booster Shot To Win $5bn Contract (DM)

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant’s bivalent Covid booster. Vaccine advisors who signed off on the updated shot late last year claim they were not shown trial data that indicated the booster was actually less effective at preventing Covid than the older vaccine it was meant to replace. While the early trial results had substantial limitations, ‘disappointed’ and ‘angry advisors say its omission from panel discussions shows a remarkable lack of transparency. US taxpayers ended up shelling out nearly $5billion on the new booster, which was intended to enhance immunity against new variants.

For new vaccines to be approved, both the FDA and Centers for Disease Control and Prevention (CDC) must convene their advisory boards and make presentations to a panel of advisors. This panel of objective reviewers then votes on whether or not to recommend its approval. It is these independent advisors – including infectious disease experts and vaccinologists from Stanford, the University of Pennsylvania and Harvard – who are now raising concerns about the partial information shown to them during approval discussions for the bivalent booster. At both an FDA meeting in June and a CDC advisory panel in September, experts were shown reams of information suggesting that the new bivalent vaccine was more effective than its predecessor.

These results were based on lab tests in which blood taken from bivalent vaxxed people were exposed to omicron and then compared to samples from people vaxxed with the older shot, in order to gauge how well each elicited Covid-fighting antibodies. Other data from the same study was not presented to the panels, however, which looked at actual infections – who caught Covid-19 and who did not. The withheld data indicated that 3.2 percent of study participants who got the updated bivalent vaccine became infected – compared to just 1.9 percent of those who received the original booster.

Read more …